iRadimed (IRMD) vs Viemed Healthcare (VMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Viemed Healthcare (VMD) has outperformed iRadimed (IRMD) over the past year, gaining 38.6% versus a gain of 16.0%. Over five years, IRMD leads with a +138.5% price change compared with +65.0% for VMD. iRadimed is the larger company by market cap ($1.12 billion vs $362.6 million), about 3.1 times the size.
On valuation, Viemed Healthcare trades at a lower forward P/E (23.8x vs 35.6x for iRadimed). iRadimed pays a dividend yielding 0.88%, while Viemed Healthcare does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRMD | VMD |
|---|---|---|
| Share price | $87.45 | $9.52 |
| Market cap | $1.12B | $362.60M |
| 1-day change | +1.83% | +1.17% |
| YTD return | -10.10% | +28.13% |
| 1-year return | +15.95% | +38.57% |
| 5-year return | +138.48% | +64.99% |
| P/E ratio (TTM) | 48.85 | 26.44 |
| Forward P/E | 35.65 | 23.80 |
| EPS (TTM) | $1.79 | $0.36 |
| Dividend yield | 0.88% | 0.00% |
| Annual dividend | $0.77 | $0.00 |
| Revenue (latest FY) | $83.81M | — |
| Revenue growth (YoY) | +14.43% | — |
| Net income (latest FY) | $22.48M | — |
| Gross margin | 76.75% | — |
| Operating margin | 31.20% | — |
| Net margin | 26.82% | — |
| 52-week high | $107.90 | $12.61 |
| 52-week low | $71.34 | $6.05 |
| Distance from 52-week high | -18.95% | -24.50% |
| Analyst consensus | none | buy |
| Avg. price target upside | +34.93% | +31.30% |
| Average volume | 125.52K | 353.27K |
| Shares outstanding | 12.79M | 38.09M |
| Employees | 166 | 1,438 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- iRadimed is about 3.1 times larger than Viemed Healthcare by market value ($1.12B vs $362.60M).
- VMD has outperformed IRMD by 22.6 percentage points over the past year.
- iRadimed trades at a higher earnings multiple (48.9x vs 26.4x trailing P/E).
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
About Viemed Healthcare
VMD stock →Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Health Care · Misc Health and Biotechnology Services · 1,438 employees
IRMD vs VMD FAQ
Which is bigger, iRadimed or Viemed Healthcare?
iRadimed (IRMD) is larger, with a market capitalization of $1.12B compared with $362.60M for Viemed Healthcare (VMD).
Which stock has performed better over the past year, IRMD or VMD?
VMD returned +38.57% over the past 12 months, compared with +15.95% for IRMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, IRMD or VMD?
VMD has the lower trailing P/E at 26.4, versus 48.9 for IRMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, iRadimed or Viemed Healthcare?
iRadimed pays a dividend yielding 0.88%, while Viemed Healthcare does not currently pay a regular dividend.
Are iRadimed and Viemed Healthcare in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for iRadimed and Misc Health and Biotechnology Services for Viemed Healthcare.